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Abstract
Musical hallucinations have been 
likened to the auditory equivalent 
of Charles Bonnet Syndrome, 
which involves complex visual 
hallucinations, most often in the 
context of visual impairment. Musical 
hallucination frequently take the 
form of hymns, carols, and show-
tunes and are strongly associated 
with hearing loss, with some 
studies suggesting a prevalence of 
2.5–3.6% in the hearing impaired. 
Musical hallucinations are typically 
treated with anticonvulsant and 
anticholinesterase medications, 
with some studies having evaluated 
the efficacy of sedative hypnotics, 
antipsychotics and antidepressants 
in various psychiatric and medical 
subpopulations suggesting a 
heterogeneous spectrum of 
causes for this disorder.
We present two cases of musical 
hallucinations in both a 70-year-
old African American female with 
past psychiatric history of major 
depressive disorder who developed 
hymnal auditory hallucinations 
during an acute medical and 
psychiatric admission and an 
86-year-old Caucasian female, 
who complained of hearing 
gospel music with eventual onset 
of visual hallucinations after a 
fall at age 80. Our patients were 
successfully treated in both the 
inpatient and outpatient settings 
with atypical antipsychotics. 
The presented cases add 
to the paucity of literature 
regarding utilization of atypical 
antipsychotics for treatment 
of musical hallucinations and 
demonstrate efficacy to this effect. 
This study lends further validity to 
the use of psychopharmacologic 
agents for novel purposes that 
have yet to be fully explored.
Introduction
Musical hallucinations have been 
likened to the auditory equivalent 
of Charles Bonnet Syndrome, 
which involves complex visual 
hallucinations, most often in the 
context of severe visual impairment.1 
Musical hallucinations involve the 
development of musical auditory 
phenomena, often repetitive and 
with a strong nostalgic quality, in the 
absence of an external source.2,3 
Like Charles Bonnet Syndrome, the 
phenomena are strongly associated 
with primary sensory loss, in this 
case hearing, carrying a prevalence 
of 2.5-3.6% in the hearing impaired 
with higher prevalence in geriatric 
versus general populations.3,4 
Severity may differ from mild 
and well-tolerable to severely 
disabling, leading to impaired 
quality of life, significant distress 
and comorbid psychiatric illness.
Despite the common connection 
with auditory impairment, musical 
hallucinations are also seen in other 
settings including epilepsy, focal 
brain lesions, intoxication and acute 
medical or psychiatric illness.5,6,7 
Though they also occur in states 
of acute metabolic derangement 
and delirium, they more often are 
seen in patients with intact reality 
testing and cognitive function.3 The 
current prevailing theory regarding 
their etiology relates to hearing 
impairment causing a release 
of typical inhibitory pathways 
in auditory association cortices 
leading to erroneous feedback 
that is ultimately perceived as 
external sound.8 This hypothesis 
however, does not address the 
emergence of these symptoms in 
individuals with intact hearing or in 
those with underlying medical or 
psychiatric comorbidity. Ergo, it is 
likely that the presenting features 
represent a common outcome of 
a more heterogeneous group of 
pathophysiologic mechanisms.
In regards to treatment, there is a 
wide array of modalities that exist. 
Acetylcholinesterase inhibitors such 
as donepezil and antidepressants 
appear to be the most efficacious 
pharmacologic agents in the current 
literature, with some more mild 
cases even appearing to be able 
to be treated through reassurance 
and lifestyle modification alone.9,10,11 
However, one more recent study by 
Coehberg et al attempted to explore 
whether or not certain medications 
may be more efficacious when used 
in differing clinical sub-populations 
based on their primary presenting 
disease, be it medical or psychiatric. 
Their findings showed that while 
the two previously mentioned 
classes of medications do have 
higher efficacy than most, other 
classes such as antipsychotics 
may be more beneficial in patients 
exhibiting acute psychotic 
symptoms.12 Our study builds on 
the current literature by presenting 
two complex patients who were 
successfully treated with aripiprazole 
and quetiapine for this reason.
Case I
Our first case involved a 
69-year-old African-American 
female with past medical and 
psychiatric histories significant for 
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chronic kidney disease requiring 
hemodialysis three times per 
week, type II diabetes mellitus, 
hypertension, mild left-sided 
hearing impairment and major 
depressive disorder, severe, 
recurrent with melancholic features. 
Though psychotic symptoms had 
been noted over the course of 
her psychiatric history, they had 
been limited to paranoid ideation 
regarding hemodialysis staff 
wanting to harm the patient with 
no previous occurrence of frank 
perceptual disturbances. Prior to 
hospitalization the patient was stable 
on venlafaxine 225mg daily and 
mirtazepine 30mg nightly with full 
remission of symptoms since 2013.
According to medical records 
the patient had discontinued her 
medications in the weeks before her 
admission leading to her having an 
episode of acute decompensated 
depression. Thereafter, she suffered 
profound despondency, decreased 
oral intake, suicidal ideation, with 
a plan to end her life through 
refusal of hemodialysis and vague 
paranoid ideation involving harm 
by an unknown person. She was 
thereby transported to a local 
area hospital and admitted to the 
medical floor with psychiatry being 
consulted for further assessment. 
Admission lab data and imaging 
were found to be unremarkable. 
On initial psychiatric interview 
the patient appeared withdrawn 
and voiced complaints consistent 
with the aforementioned symptoms, 
however additionally noted that 
within the days leading to her being 
hospitalized she had begun to hear 
music. The music was described 
to be a hymn from her childhood, 
constant and external in nature. 
She was noted to initially attribute 
the music to someone playing 
outside of the room but due to its 
constancy had insight enough to 
realize that she was the source. 
On admission to the psychiatric 
unit the patient became increasingly 
despondent and isolative and 
continued to experience suicidal 
ideation with plans to refuse 
hemodialysis or nutrition. Refusal 
of oral intake soon followed. 
However, with regular visits and 
encouragement from the patient’s 
daughter she began to accept 
food and medications with more 
regularity. Paranoia and auditory 
disturbance however remained at 
roughly the same intensity with her 
musical hallucinations staying at 
a constant volume and frequency. 
Venlafaxine was increased from 
225mg daily to 300mg and oral 
aripiprazole was started at 2.5mg 
for further control of her paranoia 
and auditory phenomena. Despite 
increases in her medications, 
depressive symptoms persisted and 
in a final effort to provide relief she 
was started on Methylphenidate 
5mg twice daily. Following 
initiation of Methylphenidate 
the patient demonstrated a 
significant improvement within 
72hrs, experiencing notable 
reduction in core presenting 
symptoms – suicidality, paranoia 
and social withdrawal. Oral 
intake continued to improve, as 
did medical compliance with oral 
medication and hemodialysis.
However, despite overall 
affective improvement her musical 
hallucinations remained. Aripiprazole 
was thusly increased over the 
remainder of her hospitalization 
to a total of 10mg daily. Roughly 
seven days after the final titration 
her musical hallucinations began 
to improve, becoming quieter and 
subjectively more distant until they 
finally resolved roughly one and 
a half weeks post final titration. 
Ultimately she was discharged 
after nearly a 1-month stay on 
the unit with complete resolution 
of presenting symptomatology 
that has since been maintained 
in the outpatient setting.
Case II
Our second case involved an 
81-year-old female who carried a 
history of depression and anxiety, 
treated for many years by her 
family physician with sertraline and 
alprazolam, but did not have a prior 
history of psychosis or dementia 
and during her course was never 
under suspicion for suffering from 
delirium. It must also be noted 
that she did carry a history of mild 
bilateral hearing impairment that was 
never reported to be of significant 
clinical consequence. This patient 
was noted to have developed 
musical hallucinations after suffering 
a fall, with report indicating that 
she had been walking her dog in 
an area with a significant drop-off, 
and ultimately slipped and fell. She 
had significant injuries, developing 
cutaneous necrosis requiring 
a plastic surgery intervention. 
Head imaging at the time did not 
demonstrate significant hemorrhage 
or other structural damage. She 
developed headaches in the 
immediate aftermath of the injury, 
but did not immediately develop 
psychiatric symptoms. Around one 
year after the fall, she started to hear 
gospel music when there was none 
playing. This phenomenon was not 
problematic for the patient. In fact, 
she described it as comforting.
About one year subsequent to 
the initial musical hallucinations, 
she developed paranoia and 
delusions. She developed auditory 
hallucinations of multiple voices, 
with negative comments and threats 
of sexual and physical violence. 
She had delusions that people 
were living under her home and 
she began using the toilet in the 
dark to prevent them from seeing 
her. She also had the phone lines 
removed to keep people from 
listening to her and developed 
visual hallucinations of people. The 
patient’s daughter had complained 
that the patient would get agitated 
and talk to the voices. She made 
claims that they were trying to take 
belongings from her home and 
making threats to harm the dog. 
Initial notes from just after the 
time of the fall indicated extensive 
physical injuries but no neurological 
or psychotic sequelae. Notes from 
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the next two years indicate anxiety 
as an ongoing problem, but do 
not reference any of the psychotic 
symptoms. A note from the patient’s 
daughter included in the chart from 
around two years after the accident 
references hearing voices, not 
sleeping, acting paranoid and fearful. 
The family physician at that point 
started the patient on lithium 150 mg 
daily. She had some improvement in 
mood stability but the confusion and 
auditory hallucinations persisted. The 
patient’s PCP had also uncovered 
and treated a UTI, which seemed 
to be exacerbating the symptoms. 
The family physician had been 
gradually decreasing the patient’s 
sertraline dose, and around four 
years after the accident, sertraline 
was at 50 mg. She was still on 
alprazolam 0.5 mg three times 
daily and lithium 150 mg daily. 
She had an abnormal neurological 
exam at that point and was sent 
to the hospital for evaluation for 
possible stroke. Records from the 
emergency room indicate patient 
had a head CT that showed 
chronic ischemic changes of mild 
to moderate severity. There was no 
indication of stroke, and the patient 
was diagnosed with Bell’s palsy.
A few months after the Bell’s 
palsy, the patient had a trial of 
going off of lithium. She became 
more confused, wasn’t sleeping, 
and seemed more depressed. 
Lithium was restarted and patient 
was started on quetiapine 50 
mg at bedtime. Alprazolam had 
continued at same dose throughout. 
Hallucinations of voices were 
still noted to persist. At this time, 
she was referred to psychiatry 
for evaluation and treatment.
At the initial visit, the psychiatrist 
titrated quetiapine up to 100 mg 
at bedtime and stopped lithium 
“due to lack of effect.” Subsequent 
phone note indicates that off of 
lithium the patient again developed 
mood instability, this time including 
agitation. She once again did not 
sleep for several nights in a row 
and paranoia was increased. The 
psychiatrist restarted lithium at 150 
mg daily. Her mood was re-stabilized 
with the resumption of lithium. 
Quetiapine was gradually titrated 
up to 200 mg as patient was noted 
to improve significantly in terms 
of paranoia and hallucinations. 
There was a brief trial of increasing 
sertraline, but patient seemed to do 
worse on the higher dose, and so the 
psychiatrist tapered off of sertraline. 
At this point, the patient was on 
lithium 150 mg daily, alprazolam 
0.25 mg in afternoon and 0.5 mg 
at bedtime, and quetiapine 200 
mg at bedtime. She has remained 
relatively stable on this regimen 
in terms of mood stability. Mild 
auditory hallucinations of both 
music and derogatory voices 
continue intermittently, but the 
patient is no longer troubled by the 
symptoms. Patient has had mild 
renal impairment, with estimated 
GFR at 46 mL/min. Lithium 
remained steady at 0.4 meq/L. 
Discussion
Musical hallucinations have 
been reported since 1846, yet a 
paucity of strong clinical data exists 
regarding treatment regimens and 
their efficacy.11 Recent studies 
have evaluated several classes 
of medications and their uses in 
various clinical populations. As 
previously mentioned, the study 
performed by Coebergh et al 
stratified subgroups of patients 
based on medical and psychiatric 
illness and postulated that in the 
psychiatric groups it appeared that 
the type of disorder was the most 
important guide as to the choice 
of treatment.12 In our cases the 
most closely associated symptom 
was psychosis, thereby the choice 
to utilize atypical antipsychotics 
was made for this reason. 
Being largely associated with 
deafferentiation phenomena, 
it is hypothesized that musical 
hallucinations are evoked through 
the absence of normal auditory 
input, thereby the mechanism by 
which antipsychotics would provide 
relief still remains unknown in this 
context. One author has suggested 
that it may be possible that 
antipsychotics restore an underlying 
aberrant process to baseline function 
at the neurotransmission level, 
resulting in remission of symptoms.13 
In other studies these auditory 
phenomena typically demonstrate 
rapid resolution in response to 
antipsychotic initiation as was seen 
in our first case. Our second case 
however demonstrated a much 
slower and incomplete resolution, 
similar to what has been seen in 
a report by Peritogiannis et al.13 
The difference in symptomatic 
resolution may suggest differences 
in either the underlying etiology of 
the disorder or perhaps the sub-
class of the medication used. 
Though the outcomes in our 
cases were largely positive and 
the chronology of drug initiation 
to symptomatic improvement 
suggestive of atypical antipsychotics 
being efficacious in this regard, 
several arguments must be noted. 
For example, though our first patient 
had demonstrated resolution of 
symptoms nearest to the final 
increase in her aripiprazole, it 
cannot be ruled out that her other 
medications may have had a role. 
It has been shown previously that 
antidepressants are quite efficacious 
in treating musical hallucinations in 
those suffering from a depressive 
disorder.11 Thereby, the time 
from the increase in the patient’s 
venlafaxine to her abatement of 
symptoms makes the attribution 
of clinical success solely to her 
antipsychotic regimen unclear. In our 
second case however the increase 
in quetiapine appears to be more 
clearly associated with the resolution 
of the patient’s symptoms, providing 
stronger evidence that the increase 
in dose of her atypical antipsychotic 
was central to her improvement.
Additionally, given the underlying 
medical pathology in both patients, 
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it cannot be ruled out that the 
resolution of their symptoms was 
not merely due to the natural course 
of an unknown underlying medical 
disease process. It could also be 
argued that our patient’s known 
hearing impairment may have been 
a contributor to the development 
of their perceptual disturbances. 
However, given the long-standing 
nature of these findings without 
previous development of auditory 
phenomena, they were not 
considered to be significant 
contributing factors in these cases. 
It was also considered as to 
whether delirium or an underlying 
neurocognitive disorder may have 
been at play in the development of 
both patients’ symptoms, however 
given negative imaging and intact 
cognitive function in both cases this 
was also felt to be noncontributory. 
Therefore, given the chronicity of the 
development of symptoms to serious 
medical illness or trauma, and the 
absence of previous perceptual 
symptoms in these patients, we 
posit that the underlying cause 
of their musical hallucinations 
was likely due to either vascular 
or metabolic pathology.
Overall, our cases add to the 
literature by illustrating musical 
hallucination manifestation in two 
very different scenarios in which 
multiple psychiatric and medical 
comorbidities were at play through 
either metabolic derangement 
as in the first case or direct head 
trauma as in the second. These 
cases provide a window into 
differentiating the patients’ musical 
phenomena from their primary 
underlying psychiatric illness. While 
there are multiple factors at work in 
both scenarios, the improvement 
of symptoms with initiation 
of antipsychotic medications 
suggests they played a large role 
in symptomatic improvement. 
Conclusion
The presented cases add 
to the paucity of literature 
regarding utilization of atypical 
antipsychotics for treatment 
of musical hallucinations and 
demonstrate efficacy to this effect. 
This study lends further validity to 
the use of psychopharmacologic 
agents for novel purposes that 
have yet to be fully explored.
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